Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Published research puts oral absorption anywhere from about 1% to 30%, depending on the person and the dose
You could be spending good money on something that wont fix the problem
GLP-1 Support Program $100/visit (Packages available) If insurance covers your medication, get expert care to maximize your success
Key Takeaways No published human trial on 5-Amino-1MQ has tracked participants beyond 12 weeks, meaning long-term safety data in humans does not exist as of 2026
Refrigeration is required: store the vial at 2-8C (36-46F)
US$ 21.46
US$ 22.41
US$ 28.63
US$ 21.77
US$ 26.89
